Measure at a Glance
Type: calculated percentage
Denominator: unique patients
Duration: calculated over the entire EHR reporting period
Objective: Maintain active medication allergy list.
Measure: More than 80 percent of all unique patients seen by the EP have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data.
Exclusion: No exclusion.
There are no changes to this objective and measure regardless of when EPs attest to Stage 1 Meaningful Use.
The attestation portal will require the EP to enter the numerator and denominator of the measure as defined in the technical specification.
Please note that this measure requires more than 80% of all unique patients. The attestation numerators and denominators are calculated to the hundredths place in the attestation portal, so while a proportion of 80.01% will be evaluated as a successful attestation, 80.00% will not.
This measure, in conjunction with Core Measures 3 and 5, requires the highest percent of unique patients have data maintained by certified EHR technology. There are no exclusions—if an EP does not have more than 80% of her unique patients entered into the certified EHR technology, she cannot successfully attest to Stage 1 Meaningful Use.
A question at the beginning of the core measures attestation will require EPs to report how many of their unique patients have their data in the EHR system. The denominator will be all unique patients seen by the EP during the EHR reporting period, as in Core Measures 3, 5, 6, and 7. One way to approach the numerator is to use the lowest numerator of Core Measures 3, 5, and 6, but other determinations of how many patients have their data in the EHR are acceptable given the resulting percentage is greater than 80%.
Relevant CMS FAQs
None at this time.
None at this time.
CMS' Final Rule
§ 495.6(d)(6) see objective and measure above
§ 170.302(d) Maintain active medication list. Enable a user to electronically record, modify, and retrieve a patient's active medication list as well as medication history for longitudinal care.
§ 170.207(e) Maintain active medication allergy list. Enable a user to electronically record, modify, and retrieve a patient's active medication allergy list as well as medication allergy history for longitudinal care.